## Page 1

172•TheJournalofNeuroscience,January5,2011•31(1):172–183
Behavioral/Systems/Cognitive
Phosphodiesterase-4D Knock-Out and RNA
Interference-Mediated Knock-Down Enhance Memory
and Increase Hippocampal Neurogenesis via Increased
cAMP Signaling
Yun-FengLi,1,2Yu-FangCheng,1,2YingHuang,1,3MarcoConti,4StevenP.Wilson,5JamesM.O’Donnell,1,3
andHan-TingZhang1,2
Departmentsof1BehavioralMedicineandPsychiatry,2PhysiologyandPharmacology,and3NeurobiologyandAnatomy,WestVirginiaUniversityHealth
SciencesCenter,Morgantown,WestVirginia26506,4DivisionofReproductiveBiology,DepartmentofObstetricsandGynecology,UniversityofCalifornia,
SanFrancisco,California94143,and5DepartmentofPharmacology,Physiology,andNeuroscience,UniversityofSouthCarolinaSchoolofMedicine,
Columbia,SouthCarolina29208
Phosphodiesterase-4(PDE4)playsanimportantroleinmediatingmemoryviathecontrolofintracellularcAMPsignaling;inhibitionof
PDE4enhancesmemory.However,developmentofPDE4inhibitorsasmemoryenhancershasbeenhamperedbytheirmajorsideeffect
ofemesis.PDE4hasfoursubtypes(PDE4A–D)consistingof25splicevariants.MicedeficientinPDE4Ddisplayedmemoryenhancement
inradialarmmaze,watermaze,andobjectrecognitiontests.Theseeffectsweremimickedbyrepeatedtreatmentwithrolipramin
wild-typemice.Inaddition,similarlyasrolipram-treatedwild-typemice,PDE4D-deficientmicealsodisplayedincreasedhippocampal
neurogenesisandphosphorylatedcAMPresponseelement-bindingprotein(pCREB).Furthermore,microinfusionoflentiviralvectors
thatcontainedmicroRNAs(miRNAs)targetinglong-formPDE4Disoformsintobilateraldentategyriofthemousehippocampusdown-
regulatedPDE4D4andPDE4D5,enhancedmemory,andincreasedhippocampalneurogenesisandpCREB.Finally,whilerolipramand
PDE4Ddeficiencyshortened(cid:1)2adrenergicreceptor-mediatedanesthesia,asurrogatemeasureofemesis,miRNA-mediatedPDE4D
knock-downinthehippocampusdidnot.ThepresentresultssuggestthatPDE4D,inparticularlong-formPDE4D,playsacriticalrolein
themediationofmemoryandhippocampalneurogenesis,whicharemediatedbycAMP/CREBsignaling;reducedexpressionofPDE4D,
oratleastPDE4D4andPDE4D5,inthehippocampusenhancesmemorybutappearsnottocauseemesis.Thesenovelfindingswillaidin
thedevelopmentofPDE4subtype-orvariant-selectiveinhibitorsfortreatmentofdisordersinvolvingimpairedcognition,including
Alzheimer’sdisease.
Introduction genetic approaches (Bourtchouladze et al., 2003). Consistent
Phosphodiesterase-4 (PDE4), an enzyme that catalyzes cAMP withthis,PDE4isinvolvedinhippocampalneurogenesis,which
hydrolysis,playsanimportantroleinthemediationofmemory. isassociatedwithlearningandmemory(Bruel-Jungermanetal.,
InhibitionofPDE4byrolipram,aselectivePDE4inhibitor,in- 2005; Epp et al., 2007). Chronic rolipram treatment increases
creasescAMPandphosphorylationofCREB(Schneider,1984;Li proliferation and survival of newborn neurons in the dentate
et al., 2009), facilitates induction of hippocampal long-term gyrus; this is mediated by cAMP/cAMP response element-
potentiation(LTP)(Baradetal.,1998),andenhancesmemory binding protein (CREB) signaling (Nakagawa et al., 2002a,b;
(Romano et al., 1996; Otmakhov et al., 2004). It also reverses Fujiokaetal.,2004;Sasakietal.,2007).Thus,PDE4inthehip-
memory deficits produced by pharmacological (Egawa et al., pocampusisanimportantcomponentofcellularsignalingthat
1997;Zhangetal.,2000,2004),physical(Imanishietal.,1997),or mediatesmemory.
PDE4hasfoursubtypes(PDE4A-D)thatareexpressedasat
ReceivedOct.5,2010;acceptedOct.24,2010. least25distinctsplicevariants(Houslay,2001;Contietal.,2003;
ThisworkwassupportedbyresearchgrantsfromNationalAllianceforResearchonSchizophreniaandDepression Cheungetal.,2007;Chandrasekaranetal.,2008;Zhang,2009).
andNationalInstituteonAging(AG031687toH.-T.Z.)andtheNationalInstituteofMentalHealth(MH051175and Their differential distributions in brain regions (Cherry and
MH040697toJ.M.O.).
Davis,1999;Perez-Torresetal.,2000)indicatedistinctrolesof
CorrespondenceshouldbeaddressedtoDr.Han-TingZhang,DepartmentofBehavioralMedicineandPsychiatry,
WestVirginiaUniversityHealthSciencesCenter,Morgantown,WV26506-9137.E-mail:hzhang@hsc.wvu.edu. individualPDE4subtypesinCNSfunctions.Limitedstudiesto
Y.-F.Li’spresentaddress:BeijingInstituteofPharmacologyandToxicology,Beijing100850,China. date have shown that PDE4B is associated with schizophrenia
Y.-F.Cheng’spresentaddress:DepartmentofPharmacology,SchoolofPharmaceuticalSciences,SouthernMed- (Millar et al., 2005) and anxiety (Zhang et al., 2008), whereas
icalUniversity,Guangzhou510515,China.
PDE4D is important for antidepressant activity (Zhang et al.,
DOI:10.1523/JNEUROSCI.5236-10.2011
Copyright©2011theauthors 0270-6474/11/310172-12$15.00/0 2002).Whilelackingcleardemonstration,PDE4Dappearstobe

## Page 2

Lietal.•PDE4D,Neurogenesis,andMemory J.Neurosci.,January5,2011•31(1):172–183•173
themajorsubtypeinmediatingmemorybasedonitspredomi-
nantexpressioninhippocampalCA1(Perez-Torresetal.,2000),
itsmajorroleincAMPhydrolysis(Zhangetal.,2002)andhip-
pocampalLTP(Ruttenetal.,2008),andonthefindingthatphar-
macologically induced overexpression of PDE4D impairs
memory (Giorgi et al., 2004). Unfortunately, development of
PDE4inhibitorsfortherapeuticpurposeshasbeenhinderedby
sideeffectssuchasemesis(Robichaudetal.,2001),whichappears
tobePDE4subtypespecific(Robichaudetal.,2002b).
PDE4variantsaredividedintofourgroups:long-form,short-
form,supershort-form,anddead-shortformPDE4s.Long-form
PDE4s are characterized by two unique, upstream conserved
regions (UCR1 and UCR2) in the N terminus; short-form
(PDE4B2,D1,andD2)andsupershort-formPDE4s(PDE4A1,
B5, D6, and D10) lack the UCR1 or UCR1 plus a portion of
UCR2, respectively; dead short-form PDE4s (such as inactive
PDE4A7) (Johnston et al., 2004) lack both UCR1 and UCR2
Figure1. Schedulesofdrugtreatmentsandtests.a,Treatmentscheduleandtestorderfor
(Houslay,2001;O’DonnellandZhang,2004;Houslayetal.,2007;
micedeficientinPDE4Dandtheirwild-typecontrols.BrdU(100mg/kg)wasinjected(i.p.)once
Lynexetal.,2008;Zhang,2009).Long-formandtheotherPDE4 dailyondays10,12,and14afterrolipramtreatment.Behavioraltestswerecarriedoutondays
categoriesappeartobedifferentiallyexpressedinbrainregions 15–22(1haftertheinjectionofrolipramorvehicle).b,Treatmentscheduleandtestorderfor
(Perez-Torresetal.,2000;McPheeetal.,2001;Miro´ etal.,2002). micetreatedwithlentiviralvectors.BrdUwasinjectedthreetimeswith3hintervals.Thenext
GiventhatPDE4variantsaretargetedtodiscretesignalingcom- day,lentiviralvectorscontaining4DmiRsortheNCsequencewereinfusedintobilateraldentate
plexes (Houslay, 2010) and that knock-down of specific PDE4
gyri(4(cid:1)106TU/(cid:2)l/side)ofthemousehippocampus.Behavioraltestswerecarriedouton
variantsusingsmallinterferingRNAs(siRNAs)exhibitsdifferent days10–14.Rolipram(1.25mg/kg)oritsvehicle(salinecontaining5%DMSO)wasinjected
(i.p.)oncedailyfor26d(a)or16d(b),afterwhichtheanimalswerekilled.MWM,Morriswater
cellular actions in vitro (Lynch et al., 2005; Kolosionek et al.,
maze;OF,openfield;OR,objectrecognition;LV,lentiviralvectors;SD,step-downpassiveavoid-
2009), it was of interest to know whether targeting long-form
ance;SAC,sacrifice.
PDE4s,whicharemostimportantforcAMPhydrolysis(Baillieet
al.,2000),alteredmemory.
riswatermaze,andstep-downpassiveavoidancetestswereperformed
MaterialsandMethods (Fig.1a,b).
Animals Plasmidconstruction
AdultmalemicedeficientinPDE4Dandthewild-type(WT)controls OligonucleotidesencodingmiRNAsthattargetlong-formPDE4Diso-
weighing24–28ghadthesamemixedgeneticbackground(C57BL/6(cid:1)
forms(seePDE4D-miRNAknock-down)weredesignedusingInvitro-
129/Ola).Theyweregenerated,bred,andgenotypedfollowingthepro- genBLOCK-iTPolIImiRRNAiexpressionvectorkitsandtheassociated
ceduresdescribedpreviously(Hansenetal.,2000;Zhangetal.,2002). software.InvitrogenNCsequenceswereusedasthecontrolofPDE4D
AdultmaleICRmiceweighing22–26gwereusedforexperimentsusing miRNAs.AllthemiRNAsandNCsequenceswereclonedintolentiviral
lentiviralvector/microRNA(miRNA)microinfusions.Allanimalswere transfervectorsanddrivenbythephosphoglyceratekinase-1promoter.
housedinatemperature-controlledanimalfacilitywitha12hlight-dark Alloftheviralvectorscontainedtheenhancedgreenfluorescenceprotein
cycle(lightsonat6:00A.M.).Waterandfoodwerefreelyavailablein (EGFP)asareportertotracklentivirus-mediatedexpressionusingfluo-
theirhomecages,exceptfortheradialarmmazetest,duringwhichfood rescencemicroscopy.
wasrestrictedto2gpermouseeachdayaftertestsessionstomaintain
bodyweightsat85–90%offree-feedingweights.Blindobservationswere Preparationoflentiviralstocks
usedthroughouttheexperiments,whichwerecarriedoutfrom9:30A.M. TheviralparticleswereproducedbytransienttransfectionofHEK293T
to4:30P.M.inaquietroom.AllproceduresfollowedtheNationalInsti- cellswithtransferplasmidcontainingEGFPand4DmiRorNC,packag-
tutesofHealth(NIH)GuidefortheCareandUseofLaboratoryAnimals ingplasmidpCMV(cid:2)R-8.92,pMD.Gplasmid(vesicularstomatitisvirus
(NIHPublicationsNo.80-23,revised1996)andwereapprovedbythe glycoprotein G envelope), and pRSV-Rev (Rev protein) as described
Animal Care and Use Committee of West Virginia University Health previously(Zalaetal.,2004).Thesupernatantwascollected48hlater
SciencesCenter(Morgantown,WV). and the virus was precipitated in the presence of polyethylene glycol,
resuspended,andpurifiedbycentrifugationthroughacushionof20%
Drugsandtreatments
sucrose.Toensurecomparabilityamongdifferentviruspreparations,the
Pentobarbital,ketamine,xylazine,andbromodeoxyuridine(BrdU)were virusconcentrationwasdeterminedbyreal-timePCRtomeasurethe
purchasedfromSigma-Aldrich;rolipramwaspurchasedfromA.G.Sci- numberofintegratedcopiesofHEK293Tcellsandreportedastransduc-
entific.Allthedrugsweredissolvedinsalineexceptforrolipram,which ingunits(TU;basedonthenumberofintegratedcopies).Aftertrans-
wasdissolvedinsalinecontaining5%dimethylsulfoxide(DMSO).The duction,thevectorswerere-suspendedin10%sucrose/PBSandstoredat
injection(i.p.)volumewas10ml/kgbodyweight. (cid:3)80°Cuntiluse.
InexperimentsusingWTandPDE4Dknock-out(4DKO)mice(Fig.
1a),rolipram(1.25mg/kg)orvehicle(5%DMSO)wasgivenoncedaily PDE4D-miRNAknock-down
for26d;BrdU(100mg/kg)wasinjected(i.p.)oncedailyondays10,12, Lentiviral miRNA-mediated knock-down (Stegmeier et al., 2005) was
and14oftherolipramtreatmentperiod.InexperimentsusingICRmice used to silence PDE4D genes. The sequence for the PDE4D miRNA
treatedwithlentiviralvectorscontainingnegativecontrol(NC)nucleo- (shRNA-mir hairpin structure) was 5(cid:4)-AATGGAGTCACAATCAAGTCA-
tides(Invitrogen)ormiRNAstargetinglong-formPDE4Ds(4DmiRs) GTTTTGGCCACTGACTGACTGACTTGAGTGACTCCATT-3(cid:4). The
(Fig.1b)(seePDE4D-miRNAknock-down),BrdU(100mg/kg)wasin- boldsequence(first21nt)istheantisensetargetsequence.Thefinalse-
jectedthreetimeswitha3hintervalbetweeninjections,followedthenext quence(italics)representsnt1–8and11–21ofthesensetargetsequence.
day(day1)byvectormicroinfusionsandrolipramorvehicle,whichwas ThismiRNAsequencetargetsnucleotides642-662oftheratPDE4D4cod-
givenoncedailyfor16d.Onehouraftertheinjectionofrolipramor ingsequence(GenBankaccessionno.AF031373),whichcorrespondsto
vehicleondays15–22or10–14,theopenfield,objectrecognition,Mor- amino acids 214–221 within the UCR1 domain of long-form PDE4D

## Page 3

174•J.Neurosci.,January5,2011•31(1):172–183 Lietal.•PDE4D,Neurogenesis,andMemory
isoforms (Bolger et al., 1997); the NC sequence from Invitrogen was familiarobjectswasreplacedwithanovelobject.Thetimeofexploration
5(cid:4)-GAAATGTACTGCGCGTGGAGACGTTTTGGCCACTGACTGACG- ofeachobject[T andT forfamiliar(f)andnovel(n)objects,respec-
f n
TCTCCACGCAGTACATTT-3(cid:4).Inboth4DmiRandNCsequences,the tively] was recorded for determination of the recognition index (RI):
middle19nt(underlined)wereconstantandcamefromthemiR-155hair- RI(cid:6)T /(T (cid:7)T).Rolipramwasgiven1hbeforethetest.
n n f
pinloop;theNCwasslightlydifferentintheloopregionandispredicted Morriswatermazetest.Thiswascarriedoutasdescribedpreviously
nottotargetanyknownvertebrategenebasedonthedemonstration (Zhangetal.,2008).Theapparatusconsistedofacircular,plasticpool
fromInvitrogen. (95cmdiameter(cid:1)25cmhigh)locatedinawellilluminatedroomwith
externalcuesvisiblefromtheinsideofthepool,whichwasfilledwith
Mousesurgeryandlentiviralmicroinfusions
opaquewater(21(cid:5)1°C).Ahiddencircularplatform(8.5cmdiameter(cid:1)
Allsurgerywasperformedunderasepticconditions.Micewereanesthe- 15.5 cm high) was submerged 1 cm under the water in one of four
tizedwithketamine(100mg/kg)andxylazine(20mg/kg)beforethey quadrants.Theacquisitiontrials(trainingtoescapetothehiddenplat-
wereplacedinastereotaxicholder(Stoelting).A30gaugeinfusioncan-
form)werecarriedoutforthreeconsecutivedays(6trials(cid:1)2dplus4
nula(PlasticsOne)wasinsertedintothedorsaldentategyrus(anterior-
trials(cid:1)1d)startingfromday15(Fig.1a).Thelatency(i.e.,thetime
posterior,(cid:3)1.7mmfrombregma;medial-lateral,(cid:5)1.8mmfromthe takentoclimbontotheplatform)foreachmousewasrecordedand,24h
midline;dorsal-ventral,(cid:3)2.0mmfromthedura)(PaxinosandFranklin, afterthelastacquisitiontrial(i.e.,day18),theprobetrialwasperformed
2001)oneachside.Lentiviralvectors(4(cid:1)106TU/(cid:2)l,1(cid:2)l/side)con- withtheplatformremovedtomeasurespatialmemory.Themousewas
tainingNCor4DmiRwereinfusedatarateof0.2(cid:2)l/minusingamicro- allowedtoswimfor60s.Thenumberofentriesintoandtimespentinthe
injection pump (CMA/Microdialysis). Behavioral experiments were targetquadrantwheretheplatformwaspreviouslylocatedweredeter-
carriedout10–14daftertheinfusions.Onday16,micewereperfused mined1haftertheinjectionofrolipram(1.25mg/kg)orvehicle.
transcardiallyandthebrainspostfixedanddehydratedbeforecoronal Step-downpassiveavoidancetest.Thiswasperformedasdescribedpre-
sections(30(cid:2)m)asdescribedpreviously(Lietal.,2009).Expressionof viously(MauriceandPrivat,1997)withminormodifications.Thetest-
themiRNAs,whichwereindicatedbyEGFP,wasexaminedusingfluo-
ingapparatusconsistedofonesideofaPlexiglaschamber(28(cid:1)17(cid:1)25
rescenceandconfocalmicroscopy(ZeissLSM510). cmhigh;ENV410B,MedAssociates).Duringthetrainingonday13(Fig.
1b),eachmousewasplacedonawoodenplatform(15.5(cid:1)8(cid:1)2.5cm
Behavioralexperiments high),whichwasfixedtothegridfloor,andsubjectedtoafootelectric
Threebatchesofmice(7–10micepergroup)wereusedforthebehavioral shock (0.4 mA for 5 s) once it completely descended onto the floor;
andneurochemicaltests.OnebatchofPDE4D-deficientmiceandWT animalsthatsteppeddownwithin60swereimmediatelytrainedinan-
littermateswasspecificallyusedforexaminingtheeffectsofPDE4Dde- othersession.Sessionswerecontinueduntilthemousestayedonthe
ficiencyonmemoryusingtheradialarmmaze,giventhatthetestre- platformfor60s;themousewasthenconsideredtohavelearnedthetask.
quires food restriction and long-term training (Zhang et al., 2000). Theretentiontestwasperformed24hafterthetraining(i.e.,day14)
AnotherbatchofPDE4D-deficientandWTmicewasusedforassessing usingthesameprocedureexceptthatnoshocksweredelivered;thestep-
theeffectsofPDE4Ddeficiencywithorwithoutrolipramtreatmenton downlatencywasrecorded,withanuppercutofftimeof300s.Rolipram
behavior using the open field, object recognition, and water maze wasgiven1hbeforetheretentiontest.
tests(Fig.1a).AsubgroupofPDE4D-deficientandWTmicewasused
Aftercompletionofthebehavioralexperiments,i.e.,(cid:8)1hafterthelast
forexaminingxylazine/ketamine-inducedanesthesia.Thethirdbatch injectionofrolipramorvehicle,BrdU-treatedmice(halfofthemicein
was ICR mice, which were used for testing the effects of PDE4D each group) were perfused and brain coronal sections (30 (cid:2)m) were
miRNAswithorwithoutrolipramtreatmentusingopenfield,object obtainedforimmunohistochemicalanalysis.Theotherhalfofthemice
recognition,andstep-downpassiveavoidancetests(Fig.1b).Allthe in each group were decapitated, their brains removed, and the hip-
behavioraldatawererecordedmanuallybyanexperimenterblindto pocampus (for noninfused mice) or the punches (3 mm in diameter
thegenotypeandtreatment. surrounding the injection site) of hippocampal tissues (for vector-
Radial arm maze test. This was performed as described previously
infusedmice)weredissectedoniceandstoredat(cid:3)80°CbeforeWestern
(Zhangetal.,2000)withminormodifications.Miceweretrainedtofind blotting.
foodpellets(FruitCerealSpins,GreatValue,WAL-MART;eachwassplit Open-fieldtest.Thiswasperformedasdescribedpreviously(Zhanget
intoeightsmallpellets)infourrandomlyselectedarmsintheeight-arm al.,2008)withminormodifications.Onday20(for4DKO/WTmice)
radialmaze(25(cid:1)7.5(cid:1)6cmhighforeacharmand20cmindiameterfor (Fig.1a)ord10(for4DmiR/NC-treatedmice)(Fig.1b),1hafterthe
thecentralplatform),whichwaselevated43cmabovethefloor.The injectionofrolipramorvehiclethemicewereplacedindividuallyina
sessioncontinueduntilthemousecollectedallfourpelletsoffoodor10
whitePlexiglasbox(60(cid:1)60(cid:1)15cm)withthefloordividedintofour
minhadpassed,whichevercamefirst.Experimentswereperformedina identicalsquaresinadimroom.Linecrossings(withallfourpawsplaced
wellilluminatedroomthatcontainedseveralvisualcuestoaidinspatial intoanewsquare)andrears(withbothfrontpawsraisedfromthefloor)
localization. Frequencies of working memory errors (i.e., entries into wererecordedina5minperiod.
baited arms that had already been visited during the same trial) and Alpha2adrenergicreceptor-mediatedanesthesia.Thiswasperformedas
referencememoryerrors(i.e.,entriesintounbaitedarms)werecalcu- describedpreviously(Robichaudetal.,2002a)using4DKOmiceand
latedasthenumberoftherespectiveerrorsdividedbythetotalnumber
WTmicetreatedwithrolipram(1mg/kg)or4DmiR(4(cid:1)106TU/(cid:2)l/
ofarmentries.Theaverageexplorationtime,ameasurementofgeneral side,intra-DG;2wbeforethetest).Inbrief,animalswereinjected(i.p.)
locomotoractivity(Zhangetal.,2000),wascalculatedasthetestdura- withxylazine(10mg/kg)/ketamine(80mg/kg)15minaftertheinjection
tion(i.e.,thetimespentincollectingallthepelletsinthemaze)divided ofrolipramorvehicle.Oncetheanimalsbecameataxic,theywereplaced
bythetotalnumberofarmsentries.Theaverageofthevaluesfromthe in the supine position in V-shaped metal troughs (covered by paper
dailytwosessionswascalculatedforeachindex. towels).Thedurationofanesthesiawasdeterminedasthetimebetween
Objectrecognitiontest.Thetestwascarriedoutasdescribedpreviously thelossandreturnoftherightingreflex;thelatterwasdefinedaswhen
(deLimaetal.,2005).Onday20or10(i.e.,20or10daftertreatmentwith animalscouldrightthemselvesthreetimeswithin30safterbeingplaced
rolipramorvehicle)(Fig.1a,b),eachmousewasallowedtomovefreelyin ontheirbacks.
anopen-fieldboxfor5minashabituation;locomotoractivitywassimul-
taneouslyrecorded(seeOpen-fieldtest).Twenty-fourhourslater,mice Westernblotting
wereindividuallyplacedinthecenteroftheboxcontainingtwoidentical HippocampaltissueswereprocessedandWesternblotanalysiswasper-
objects(Legoblocks)locatedinthetwodiagonalcorners.Thecumula- formedasdescribedpreviously(Lietal.,2009).Samples(70(cid:2)gprotein
tivetimespentinexploringeachobjectwasrecordedduringa5min each)wereseparatedusingSDS-PAGEandthentransferredtonitrocel-
period.Explorationwasdefinedasactivelytouchingorfacing(within2 lulose membranes. These were then incubated with rabbit antisera
cmtoward)theobject.Onday22or12(24haftertraining),micewere againstpCREB(Ser133),CREB(Millipore),Sox2(MilliporeBioscience
tested for memory using the same procedure except that one of the ResearchReagents),PDE4A(Bolgeretal.,1996)(allthesewere1:1000),

## Page 4

Lietal.•PDE4D,Neurogenesis,andMemory J.Neurosci.,January5,2011•31(1):172–183•175
PDE4B (Huston et al., 1997) (1:1500), PDE4D3 (1:500), PDE4D4 (1:
1000),PDE4D5(1:500;FabGennixforallPDE4antibodiesexceptfor
PDE4D3, which was purchased from GeneTex) (Ne´moz et al., 1996;
Bolgeretal.,1997),or(cid:3)-actin(innercontrol;1:1000;Sigma)overnight
exceptfortheanti-(cid:3)-actinantibody,forwhichtheincubationwas1h.
After washing, the membranes were incubated with Alexa Fluor 700-
conjugatedgoatanti-rabbitIgG(1:20,000;Invitrogen)for30min.The
detectionandquantificationofspecificbandswerecarriedoutusinga
fluorescencescanner(OdysseyInfraredImagingSystem,LI-CORBio-
technology)at700nmwavelength.Forbandstripping,themembranes
wereincubatedwithstrippingbuffer(MilliporeBioscienceResearchRe-
agents)for15minatroomtemperature.
Immunohistochemistry
Thiswasperformedasdescribedpreviously(Lietal.,2009).Inbrief,
free-floatingbrainsectionswereusedforimmunofluorescentstainingof
BrdUanditscolocalizations;theywereincubatedfor1dwithcoldPBS-
plus, which contained rat anti-BrdU (1:200; Abcam), mouse anti-
polysialic acid neural cell adhesion molecule (PSA-NCAM) (1:200;
Millipore Bioscience Research Reagents), rabbit anti-pCREB (1:200),
mouseanti-neuronalnuclei(NeuN)(1:1000;MilliporeBioscienceRe-
searchReagents),andrabbitanti-S100(cid:3)antisera(1:100;GeneTex).After
rinsingwithPBS,thesectionswereincubatedwithFITC-conjugatedgoat
anti-ratIgG(1:200;forBrdUlabelinginWTand4DKOmice)orRho-
damineRed-X-conjugatedgoatanti-ratIgG(1:200;forBrdUlabelingin
4DmiR- or NC-treated mice to distinguish EGFP from BrdU-labeled
cells),RhodamineRed-X-conjugatedgoatanti-mouseIgG(1:200),and
Cy5-conjugatedgoatanti-rabbitIgG(1:400;JacksonImmunoResearch)
in PBS for 2 h. After rinsing, the sections were then mounted with
Vectashield medium for fluorescence imaging (Vector Laboratories).
Fluorescenceanalyseswereperformedusingconfocallasermicroscopy.
Todeterminethepercentageofnewbornneurons(PSA-NCAMimmu-
nopositive)amongBrdU-labeledcellsandexaminepCREBinthenew-
borncells(i.e.,cellslabeledforbothBrdUandPSA-NCAM),atleast50
BrdU-positivecellsinthedentategyruswererandomlyidentifiedineach
animal,forwhichthenumberofcellsineachcategorywasdetermined.
BrdU-positivecellswerecountedusingamodifiedstereologyprotocol
(Gouldetal.,1999;Lietal.,2009).Everyninthsectionthroughoutthe
Figure2. a–c,MicedeficientinPDE4D(4DKO)displayeddecreasesinfrequencyofreference
entirehippocampuswasprocessedforBrdUimmunohistochemistry.All
memoryerrors(a)butnotfrequencyofworkingmemoryerrors(b)oraverageexplorationtime
BrdU-labeled cells in the granular cell layer and hilus were counted
(c)intheeight-armradialmazetask.Thefrequencyofreferenceorworkingmemoryerrorswas
blindlythrougha60(cid:1)objectivetodistinguishindividualcells.Thenum-
calculatedasreferencememoryerrorsandworkingmemoryerrors,respectively,dividedbythe
ber of counted cells were multiplied by 10 and recorded as the total
totalnumberofarmentries;theaverageexplorationtimewascalculatedasthetestduration
numberoflabeledcellsinthedentategyrus.
dividedbythetotalnumberofarmentries.Miceweretrainedfortwosessionsadayfor14
Statisticalanalysis
successivedays.Valuesshownaremeans(cid:5)SEM;n(cid:6)6–7.**p(cid:9)0.01versustheWTcontrol.
Datashownareexpressedasmeans(cid:5)SEM.Alldatawereanalyzedusing
one-way ANOVA except for the data from the radial arm maze and
acquisitiontrainingofthewatermaze,whichwereanalyzedbytwo-way reducedfrequencyofreferencememoryerrorscomparedtoWT
repeated-measuresANOVA.Newman–Keulstestswereusedforposthoc controls on days 13 and 14 (both p (cid:9) 0.01; Student’s t tests),
multipletreatmentcomparisons.Two-tailedunpairedttestswereused indicatingenhancedlong-termmemory(Zhangetal.,2000).In
forcomparisonsbetweengenotypes(forradialarmmaze)ortreatments. contrast,frequencyofworkingmemoryerrors(Fig.2b)andthe
averageexplorationtime(Fig.2c),anindexoflocomotoractivity
Results (Zhangetal.,2000),werenotsignificantlydifferentbetweenthe
EnhancedmemoryinmicedeficientinPDE4D genotypesthroughoutthetrainingsessions.
Mice deficient in PDE4D display enhanced induction of long- Thememory-enhancingeffectofPDE4Ddeficiencywasver-
termpotentiationinhippocampalCA1slices,butcontroversially ified using the Morris water maze task, which measures
showimpairedperformanceoffearconditioning(Ruttenetal., hippocampal-dependent memory (Morris et al., 1982; Re-
2008).ToclarifythisanddeterminewhetherPDE4Ddeficiency mondesandSchuman,2004);rolipramalsowasaddedtotestthe
enhances hippocampal-dependent memory, we compared be- potentialinvolvementofotherPDE4subtypesinmemorybased
havioralperformanceof4DKOandWTmiceinvariousmemory onthestrategyusedpreviously(Zhangetal.,2002).Duringthe
tests, including the eight-arm radial maze, object recognition, 3dacquisitiontraining,allthemice,i.e.,vehicle-orrolipram-
andMorriswatermazetasks.Intheradialarmmazetest,both treatedWTand4DKOmice,displayedprogressivedecreasesin
genotypes of mice showed progressive decreases in reference thelatencytoreachthehiddenplatformovertrainingtrials(Fig.
memoryerrors(i.e.,entriesintotheunbaitedarms)duringtrain- 3a);overallstatisticalcomparisonsbytwo-wayANOVArevealed
ing(Fig.2a);overallstatisticalcomparisonsbytwo-wayANOVA significantchangesintreatment(rolipramand/orgeneknock-
revealed significant changes in genotype (F (cid:6) 4.90, p (cid:9) out; F (cid:6) 3.86, p (cid:6) 0.009), time (F (cid:6) 23.56, p (cid:9)
(1,143) (3,432) (15,432)
0.05),time(F (cid:6)5.54,p(cid:9)0.001),andinteractionofgeno- 0.0001),butnottheinteractionoftreatment(cid:1)time(F (cid:6)
(13,143) (45,432)
type(cid:1)time(F (cid:6)2.13,p(cid:9)0.05).4DKOmicedisplayed 0.80, p (cid:6) 0.82). There was no significant difference between
(13,143)

## Page 5

176•J.Neurosci.,January5,2011•31(1):172–183 Lietal.•PDE4D,Neurogenesis,andMemory
withrolipram(1.25mg/kgfor22d)displayedagreaterrecogni-
tionindex(F (cid:6)3.95,p(cid:6)0.02)intheobjectrecognitiontest
(3,27)
(Fig. 3c); post hoc Newman–Keuls tests indicated that PDE4D
deficiencyorrolipramtreatmentincreasedtherecognitionindex
relativetoWTmicetreatedwithvehicle(p(cid:9)0.05).Theeffectof
PDE4Ddeficiencywasnotchangedbyrolipram,supportingthe
importantroleofPDE4Dinthemediationofmemory.
Inagreementwiththeunchangedexplorationtimeinthera-
dialarmmazetest,PDE4Ddeficiencyorchronicrolipramtreat-
mentaloneorincombinationdidnotaltereitherlinecrossings
orrearsintheopen-fieldtest(datanotshown),suggestingthat
the memory-enhancing effects were independent of potential
changesingeneralmotoractivity.
Increasedhippocampalneurogenesisinmicedeficientin
PDE4D
PDE4hasbeenshowntobeinvolvedinhippocampalneurogen-
esis(Nakagawaetal.,2002a;Sasakietal.,2007;Lietal.,2009).To
determinewhetherPDE4Dplayedaroleinthisprocess,BrdU-
positivecellsinthedentategyrusofthehippocampuswereex-
amined16dafterthefirstBrdUinjectionin4DKOandWTmice
treated with or without rolipram (Fig. 1a); at this time point,
BrdU-positive cells represent the number of survived cells
(Schmidt and Duman, 2007). Confocal micrographs indicated
thatBrdU-positivecellswerepredominantlylocalizedinthesub-
granularzone(SGZ)(Fig.4a),whichisconsistentwithprevious
reports(Nakagawaetal.,2002a;Lietal.,2009).WTmicetreated
withrolipram(1.25mg/kgfor26d)ormicedeficientinPDE4D
displayed increases in the number of BrdU-labeled cells in the
dentategyrus(F (cid:6)4.12,p(cid:6)0.03);posthocNewman–Keuls
(3,12)
tests indicated that PDE4D deficiency or rolipram treatment in-
creasedBrdU-positivecellscomparedtoWTcontrolstreatedwith
vehicle(p(cid:9)0.05)(Fig.4b).Rolipramhadnoeffectonincreased
BrdU-positivecellsobservedin4DKOmice,indicatingthatPDE4D
isimportantlyinvolvedinhippocampalneurogenesis.
Figure3. MemoryenhancementinmicedeficientinPDE4D(4DKO)withorwithoutrolipram
(Rol)treatment.a,Escapelatencyduringtheacquisitiontrials(6trials(cid:1)2dplus4trials(cid:1)1d)
PhenotypesandcolocalizationsofBrdU-labeledcellsinthe
inthewatermazetestin4DKOmiceandtheirWTlittermates.Nodifferencebetween4DKOand
dentategyrusofmicedeficientinPDE4D
WTorrolipramandvehicle(Veh)inthesamegenotype.b,Increasedentriesanddurationinthe
BrdUstainingwascarriedout16dafterthefirstBrdUinjectionin
targetquadrantintheprobetrialofthewatermazetestin4DKOmiceorWTmicetreatedwith
WTand4DKOmice,bywhichtimenewborncellsdevelopdif-
rolipram.c,Increasedrecognitionindexintheobjectrecognitiontestin4DKOmiceorWTmice
treatedwithrolipram.Therecognitionindexwastheexplorationtimeinthenovelobject,Tn, ferentiatedphenotypes(Kempermannetal.,2003).Toexamine
dividedbythetotalexplorationtime(i.e.,Tnplustheexplorationtimeinthefamiliarobject,Tf). thephenotypeofBrdU-positivecellsinthedentategyrus,double
Rolipram(1.25mg/kg)orvehiclewasinjected(i.p.)oncedailyfor15–18d(a,b)or22d(c) labelingforBrdUandNeuN,aneuronalmarker(Mullenetal.,
beforethetest.Valuesshownaremeans(cid:5)SEM;n(cid:6)7–8;*p(cid:9)0.05,**p(cid:9)0.01versus 1992;Nakagawaetal.,2002a),orS100(cid:3),aglialmarker(Boyeset
correspondingWTplusvehicle. al., 1986; Nakagawa et al., 2002a), was performed. Analysis by
confocalmicroscopyshowedthatBrdU-positivecellscolocalized
genotypesortreatments.Incontrast,intheprobetrialtestper- withbothNeuN-andS100(cid:3)-labeledcells(Fig.4c,d),whichcom-
formed24hafterthelastacquisitiontrial,WTmicetreatedwith prised(cid:8)74and17%ofBrdU-positivecells,respectively.Neither
rolipram(1.25mg/kgfor18d)(Fig.1a)or4DKOmicetreated rolipramnor4DKOalteredthepercentageofcellsmaturinginto
withorwithoutrolipramdisplayedincreasesinentries(F (cid:6) neuronsorglialcells(Fig.4e).
(3,26)
7.52,p(cid:6)0.0009)andduration(F (cid:6)3.57,p(cid:6)0.03)inthe Newborncellsbegintobeinvolvedinlearningandmemory
(3,26)
targetquadrant(Fig.3b),asrevealedbyone-wayANOVAanal- when they are (cid:8)2 weeks of age (Shors et al., 2001; Bruel-
ysis.PosthocNewman–Keulstestsindicatedthatrolipramtreat- Jungermanetal.,2005).Newbornneurons(includingneuroblast
mentand/orPDE4Ddeficiencyincreasedbothentries(p(cid:9)0.01) types(cid:10)andIIandimmatureneurons)inthedentategyrusexpress
and duration (p (cid:9) 0.05) compared to the control of WT plus PSA-NCAM(cid:8)2weeksbeforetheymatureintogranularneuro-
vehicle,suggestingenhancedlong-termspatialmemory.Mem- nalcells(Nakagawaetal.,2002b;Encinasetal.,2006).Todeter-
ory enhancement in 4DKO mice was not affected by chronic minetheproportionofnewbornneuronsandpCREB-expressing
rolipramtreatment,indicatingapredominantroleofPDE4Din cells among BrdU-positive cells and newborn neurons, respec-
themediationofmemory. tively,coexpressionofBrdU,PSA-NCAM,andpCREBwasex-
TheroleofPDE4Dinmemorywasfurtherconfirmedusing aminedusingtriplestaining16dafterthefirstBrdUinjection.In
theobjectrecognitiontestin4DKOandWTmicetreatedwithor WTmicetreatedwithvehicle,(cid:8)85%ofBrdU-labeledcellsbe-
withoutrolipram.Consistentwiththeresultsintheradialarm camenewbornneurons,asevidencedbycolocalizationwithPSA-
maze and water maze tests, 4DKO mice and WT mice treated NCAM (Fig. 4f,g); 92% of the BrdU-labeled newborn neurons

## Page 6

Lietal.•PDE4D,Neurogenesis,andMemory J.Neurosci.,January5,2011•31(1):172–183•177
Figure4. CellslabeledforBrdUand/orNeuN,S100(cid:3),PSA-NCAM,orpCREBinthehippocampaldentategyrusinmicedeficientinPDE4D(4DKO)withorwithoutrolipram(Rol)
treatment.a,b,Confocalmicrographs(a)andquantification(b)ofBrdU-labeledcells(green)inthedentategyrusfrom4DKOorWTmicewithorwithoutrolipram.Themajorityof
BrdU-labeledcellswerelocatedintheSGZandhilus(H).While4DKOandrolipram-treatedWTmicedisplayedincreasesinBrdU-positivecells,rolipramdidnotalterBrdU-positivecells
in4DKOmice.c,d,PhenotypeofBrdU-positivecellsinthedentategyriof4DKOmice.Confocalmicrographsofcellsdouble-labeledforBrdU(green;left)andtheneuronalmarkerNeuN
(red;middleandtop)ortheglialmarkerS100(cid:3)(blue;middleandbottom).e,UnalteredpercentagesofneuronalandglialcellslabeledbyBrdUinthedentategyriof4DKOmicewithor
withoutrolipramtreatment.f,Representativeconfocalmicrographsofcellstriple-labeledforBrdU,thenewbornneuronmarkerPSA-NCAM(red),andpCREB(blue)inthedentategyri
of4DKOmice,whichindicatecolocalizationofPSA-NCAMandpCREBindevelopingBrdU-positivecells.g,UnalteredpercentagesofnewbornneuronslabeledbyPSA-NCAMin
BrdU-positivecellsinthedentategyrusfromWTor4DKOmicefollowingrolipramorvehicletreatment.PSA-NCAM-labeledcellscomprised84.5%ofBrdU-positivecells.h,Unaltered
percentagesofpCREB-labeledcellsinnewbornneuronsinthedentategyrusfromWTor4DKOmicefollowingrolipramorvehicletreatment.pCREB-labeledcellscomprised91.5%ofcells
doublelabeledforPSA-NCAMandBrdU.Miceweregivenrolipram(1.25mg/kg,i.p.)orvehicleoncedailyfor26d;BrdU(100mg/kg)wasinjected(i.p.)oncedailyondays10,12,and14.
Onday26,1haftertherolipraminjection,micewereperfusedandfrozenbrainsectionspreparedforimmunohistochemistry.Barsshownaremeans(cid:5)SEM;n(cid:6)4;*p(cid:9)0.05versus
WTplusvehicle(Veh).
expressedpCREB(Fig.4f,h).Thesepercentageswerenotchanged whether PDE4D deficiency altered pCREB in the hippocam-
byeitherrolipramtreatmentorPDE4Ddeficiency[F (cid:6)0.33, pus. Expression of Sox2, a mitotic neural progenitor cell
(3,12)
p(cid:6)0.80fornewbornneurons(Fig.4g);F (cid:6)1.40,p(cid:6)0.29 marker(Grahametal.,2003;Episkopou,2005),wasalsoex-
(3,12)
forpCREB(Fig.4h)],indicatingthattheincreaseinneurogenesis amined to determine proliferation of progenitor cells in the
wasnotcausedbyincreasednewbornneurons;pCREBmayplay hippocampus. Confocal microscopic analysis showed that
an important role in survival of newborn neurons in the hip- pCREBwaspredominantlyexpressedinthegranularcelllayer
pocampal dentate gyrus. Accordingly, we examined potential (GCL)andsubgranularzone(SGZ)ofthedentategyrus(Fig.
changesinprogenitorcellsthatresideinthesubgranularzone, 5a).MicedeficientinPDE4DorWTmicetreatedwithrolip-
proliferateandmigrateintothegranularcelllayer,andmature ram(1.25mg/kg,26d)displayedincreasesinpCREB(F (cid:6)
(3,12)
into neurons and other cell types in the hippocampal dentate 4.25, p (cid:6) 0.03) (Fig. 5b) and Sox2 (F (cid:6) 3.84, p (cid:6) 0.04)
(3,12)
gyrus(Dumanetal.,2001;vanPraagetal.,2002). (Fig. 5c) in the hippocampus; post hoc Newman–Keuls tests
indicated that PDE4D deficiency or chronic rolipram treat-
IncreasedpCREBandSox2inthehippocampusofmice ment increased expression of pCREB and Sox2 in the hip-
deficientinPDE4D pocampus compared to WT mice treated with vehicle (p (cid:9)
GiventhatcAMP/CREBsignalingiscriticalformemory(Abel 0.05). Rolipram did not alter the effect of PDE4D deficiency
andKandel,1998;Barcoetal.,2003;Montietal.,2006)and on expression of pCREB and Sox2. In contrast to pCREB,
neurogenesis(Nakagawaetal.,2002a,b;Lietal.,2009)andis CREBlevelswerenotalteredbyPDE4Ddeficiencyorrolipram
present in newborn neurons, it was of interest to know treatment (F (cid:6) 0.3, p (cid:6) 0.83; data not shown). These
(3,12)

## Page 7

178•J.Neurosci.,January5,2011•31(1):172–183 Lietal.•PDE4D,Neurogenesis,andMemory
tiviralinfusions.EGFP-positivecellsweremainlylocatedinthe
GCLandSGZ,althoughmoderateexpressionofEGFPwasob-
servedintheprojectionsextendingintotheinnerportionofthe
CA3subregion(Fig.6a,b,middleandright).Theseresultssuggest
that 4DmiR and NC were well expressed in the dentate gyrus
under the conditions used. One-way ANOVA of the immuno-
blottingdata(Fig.6c)revealedsignificantchangesinallthevari-
antsexaminedexceptforPDE4B4(4D3:F (cid:6)5.33,p(cid:6)0.01;
(3,12)
4D4:F (cid:6)4.39,p(cid:6)0.03;4D5:F (cid:6)5.57,p(cid:6)0.01;4A5:
(3,12) (3,12)
F (cid:6) 8.19, p (cid:6) 0.003; 4B1: F (cid:6) 3.95, p (cid:6) 0.04; 4B4:
(3,12) (3,12)
F (cid:6)0.27,p(cid:6)0.85)(Fig.6d,e).PosthocNewman–Keulstests
(3,12)
indicated that, compared to NC, 4DmiR alone decreased
PDE4D4(p(cid:6)0.01)and4D5(p(cid:9)0.05)butdidnotalterexpres-
sionofanyoftheotherPDE4variantsdetected(i.e.,PDE4D3,
4A5,4B1,and4B4)inpunchesofhippocampi;rolipramtreat-
ment(1.25mg/kg,16d)alonedecreasedexpressionofPDE4D4,
4D5,4B1(allp(cid:9)0.05),and4A5(p(cid:9)0.01)butincreasedex-
pressionofPDE4D3(p(cid:9)0.05)anddidnotalter4B4,relativeto
thevehicle(plusNC)control(Fig.6c–e).Inaddition,rolipram
didnotalter4DmiR-induceddecreasesinexpressionofPDE4D4
and4D5.
Memoryenhancementproducedbydownregulationof
PDE4Dvariantsinthemousehippocampus
Todeterminewhetherknock-downoflong-formPDE4Dsmim-
icked the ability of PDE4D deficiency to enhance memory, we
microinfused4DmiRorNCintobilateraldentategyri12–14d
beforeobjectrecognitionandstep-downpassiveavoidancetests
(Fig.1b).Giventheequivalentpotencyofrolipramforinhibi-
tionofallPDE4subtypes/isoforms(MacKenzieandHouslay,
2000),rolipram(1.25mg/kg)wascoadministeredwith4DmiR
todeterminethepotentialinvolvementofotherPDE4variants
inmemory.IfmiRNA-targetedlong-formPDE4Dsareimpor-
tant,inhibitionbyrolipramoftheremainingPDE4s,including
PDE4A, PDE4B, and nonlong form PDE4Ds, in the brain of
4DmiR-treatedmiceshouldnotfurtherenhancememory;oth-
Figure5. EffectsofPDE4DdeficiencyonlevelsofpCREBandSox2inthehippocampusinthe erwise, the memory-enhancing effect of long-form PDE4D
presenceorabsenceofrolipram(Rol).a,RepresentativeconfocalmicrographsofpCREB- knock-downwouldbepotentiatedinthepresenceofrolipram.
positivecells(blue)inthedentategyrusfrommicedeficientinPDE4D(4DKO)orWTcontrols
The results showed that the former was the case. Specifically,
followingchronictreatmentwithrolipramorvehicle.b,c,ChangesinexpressionofpCREB(b) one-wayANOVArevealedincreasedrecognitionindex(F (cid:6)
andSox2(c)inthehippocampusfromWTor4DKOmicetreatedrepeatedlywithrolipramor (3,31)
5.59,p(cid:6)0.004)(Fig.7a)andretentionlatency(F (cid:6)3.57,
vehicle.BottompanelsarerepresentativeimmunoblotsofpCREBorSox2detectedbyWestern (3,31)
p(cid:6)0.02)(Fig.7b)24haftertraininginmicetreatedwith4DmiR
blotting;toppanelsarethecorrespondingquantification.Whereas4DKOandrolipram-treated
WTmicedisplayedincreasesinpCREB-positivecellsandexpressionofpCREBandSox2,the and/orrolipramintheobjectrecognitionandpassiveavoidance
effectsofPDE4Ddeficiencywerenotalteredbychronicrolipramtreatment.Rolipram(1.25 tests, respectively. Post hoc Newman–Keuls tests indicated that
mg/kg)wasinjected(i.p.)onceadayfor26d;1hafterthelastinjection,micewerekilledand 12daftersingle4DmiRinfusionsordailyrolipraminjections,the
thebrainspreparedforimmunohistochemistryorhippocampiweredissectedforimmunoblot recognition index was increased in the object recognition test
analysis.Barsshownaremeans(cid:5)SEM;n(cid:6)4;*p(cid:9)0.05versuscorrespondingWTplus comparedtoNCplusvehicle(p(cid:9)0.05for4DmiRandp(cid:9)0.01
vehicle(Veh).
for rolipram) (Fig. 7a). Consistent with this, in the step-down
passive avoidance task, mice treated with 4DmiR or rolipram
resultssuggestthatPDE4Disimportantinrolipram-induced displayed increases in latency to step down from the platform
proliferationofmitoticneuralprogenitorcells,whichinvolves duringtheretentiontestperformed24hafterinitialtrainingon
activationofcAMP/CREBsignalinginthehippocampus(Liet
day14comparedtomicetreatedwithNCplusvehicle(p(cid:9)0.05)
al.,2009). (Fig.7b).Inaddition,4DmiRorrolipramdecreasedthenumber
oftrials(p(cid:6)0.02)requiredforreachingthecriteria(stayingon
DownregulationofPDE4DvariantsbyPDE4D-miRNAsin theplatformfor60s)duringthetraining(datanotshown).In
themousehippocampus bothcases,theeffectsof4DmiRonmemoryperformancewere
Todeterminetheroleoflong-formPDE4Dvariantsinmemory, notchangedinthepresenceofrolipram.Theeffectsof4DmiR
lentiviralvectorsharboringeither4DmiRs(miRNAsdesignedto and/or rolipram on memory performance were not associated
target long-form PDE4Ds) or the NC sequence were microin- withgeneralmotoractivitygiventhatthetreatmentdidnotalter
fused bilaterally into the hippocampal dentate gyri (Fig. 6a,b, linecrossings(F (cid:6)0.12,p(cid:6)0.95)orrears(F (cid:6)0.18,
(3,31) (3,31)
left).ThevectorscontainedtheEGFPsequence,whichpermitted p(cid:6)0.91)intheopen-fieldtest10dafterthelentiviralinfusions
visualizationoftheinfectioninthedentategyrus16dafterlen- (datanotshown).

## Page 8

Lietal.•PDE4D,Neurogenesis,andMemory J.Neurosci.,January5,2011•31(1):172–183•179
Figure6. Effectsofthelenti-PDE4D-miRNA(4DmiR)onexpressionofPDE4splicevariantsinthemousehippocampus,withorwithoutrolipram(Rol)treatment.a,b,Representativemicrographs
ofinjectionsitesinthehippocampus(left)andexpressionofNC(a)and4DmiR(b),indicatedbyEGFP(green;middleandrightpanels;therightpanelsaremagnificationsofthemiddlepanels),in
thedentategyrus16dfollowingbilateralmicroinfusionsofthelentiviralvectorsintothedentategyri(4(cid:1)106TU/(cid:2)l,1(cid:2)lperside).c,RepresentativeimmunoblotsofPDE4D3,4D4,4D5,4A5,4B1,
and4B4detectedbyWesternblottingusingpunchedhippocampaltissues(3mmindiametersurroundingtheinjectionholeinthehippocampus)frommicetreatedwithNCor4DmiR,withor
withoutrolipramtreatment(1.25mg/kg)thatwasinjected(i.p.)oncedailyfor16d.d,e,QuantificationofPDE4D3–5(d)andPDE4A/B(e)fromtherespectiveimmunoblots(c).Barsshownare
means(cid:5)SEM;n(cid:6)4;*p(cid:9)0.05,**p(cid:9)0.01versuscorrespondingNCplusvehicle(Veh);$p(cid:9)0.05versuscorresponding4DmiRplusvehicle.
IncreasesinpCREBandneurogenesisinthehippocampus 2002a).Whileboth4DKOmiceandrolipram-treatedWTmice
producedbydownregulationofPDE4Dvariants displayedshorteneddurationofanesthesia(F (cid:6)5.02,p(cid:6)
(3,43)
Aftercompletionofbehavioralexperiments,micewerekilledto 0.004;Newman–Keulstests,p(cid:9)0.01for4DKOandp(cid:9)0.05for
determine the effects of 4DmiR on pCREB and hippocampal rolipram)(Fig.8),4DmiR-treatedWTmicedidnotdifferfrom
neurogenesis. One-way ANOVA revealed increases in pCREB the vehicle-treated controls, suggesting that downregulation of
levelsinthehippocampus(F (cid:6)4.60,p(cid:6)0.02)(Fig.7c)and long-formPDE4Dsinthehippocampusmaynotcauseemesis.
(3,12)
BrdU-positivecellsinthedentategyrus(F (cid:6)4.43,p(cid:6)0.03)
(3,12)
(Fig.7d,e)16dafterviralmicroinfusionsordailyrolipramtreat- Discussion
ment(i.e.,17dafterBrdUinjections)(Fig.1b).Newman–Keuls PDE4playsanimportantroleinthemediationofmemory.Pre-
testsindicatedthat4DmiRorrolipramincreasedpCREBlevels treatment with the prototypic PDE4 inhibitor rolipram, either
andthenumberofBrdU-labeledcellsinthehippocampuscom- acutely or chronically, reverses memory deficits induced by a
paredtoNC(plusvehicle;bothp(cid:9)0.05).Rolipramdidnotalter varietyofmanipulations(Egawaetal.,1997;Imanishietal.,1997;
4DmiR-inducedincreasesinpCREBorBrdU-labeledcellscom- Zhang and O’Donnell, 2000; Zhang et al., 2000, 2004, 2005;
paredtocorresponding4DmiRplusvehicle(Fig.7c–e).Incon- Bourtchouladze et al., 2003). Consistent with these, chronic
trast,noneofthetreatmentsalteredCREBlevels(F (cid:6)1.03, treatmentwithrolipramenhancedmemoryinuntreatedmice;
(3,12)
p(cid:6)0.41;datanotshown).Theseresultssuggestthatlong-form this is supported by findings in previous studies (Villiger and
PDE4DvariantssuchasPDE4D4andPDE4D5areinvolvedin Dunn,1981;Romanoetal.,1996;Baradetal.,1998).However,it
cAMP/CREBsignalingandhippocampalneurogenesis. isnotclearwhichPDE4subtypeisimportantinmediatingmem-
ory,primarilybecauseofthelackofhighlyselectiveinhibitorsof
Absenceofemetic-likeresponseinlentiviral individualPDE4subtypes.Usingapproachesofgeneknock-out
PDE4D-miRNAs-treatedmice andmiRNA-inducedgeneknock-down,wehavedemonstrated
EmesisisthemajorsideeffectofPDE4inhibitors(Robichaudet thatPDE4D,inparticularitslong-formisoforms,playsanim-
al.,2001,2002a;DykeandMontana,2002).Itappearstobeas- portantroleinthemediationofmemoryandhippocampalneu-
sociated with PDE4D (Robichaud et al., 2002b). To determine rogenesis. Targeting long-form PDE4Ds appears to be a better
whetherlong-formPDE4Dvariantsinthehippocampusarein- approachtoenhancingmemorygiventhatitwasnotinvolvedin
volvedinemesis,weexaminedtheeffectsof4DmiRonxylazine/ theemeticresponse.
ketamine-inducedanesthesia,asurrogateapproachtoassessing Results from our previous studies have provided a link be-
emeticresponseinnonvomitingspecies(Robichaudetal.,2001, tweenPDE4Dandmemory(Zhangetal.,2004,2005),butthere

## Page 9

180•J.Neurosci.,January5,2011•31(1):172–183 Lietal.•PDE4D,Neurogenesis,andMemory
Figure7. Effectsoflenti-PDE4D-miRNAs(4DmiR)onmemoryandhippocampalpCREBandneurogenesis,withorwithoutrolipram(Rol)treatmentinmice.a,b,Memoryperformanceofmice
treatedwith4DmiRorNCaloneorincombinationwithrolipramintheobjectrecognitiontest(a)andstep-downpassiveavoidancetest(b).4DmiRorrolipramaloneenhancedlong-termmemory,
asindicatedbyincreasedrecognitionindexandretentionlatency,respectively,tested24haftertraining.c,IncreasedexpressionofpCREBinthehippocampusfrommicetreatedwith4DmiRor
rolipramaloneorincombination.BottompanelsarerepresentativeimmunoblotsofpCREBdetectedbyWesternblotting;toppanelsarequantification.d,e,Confocalmicrographs(d)and
quantification(e)ofBrdU-labeledcells(red)inthedentategyrusfrommicetreatedwith4DmiRorNCwithorwithoutrolipramtreatment.BrdU(100mg/kg)wasinjected(i.p.)threetimeswith3h
intervals.Twenty-fourhoursafterthefirstinjectionofBrdU,4DmiRorNCwasmicroinfusedintobilateraldentategyriusingasingledoseof4(cid:1)106TU/(cid:2)l/side,afterwhichrolipram(1.25mg/kg)
oritsvehiclewasinjected(i.p.)oncedailyfor12or14dbeforetheobjectrecognitionorpassiveavoidancetest,respectively.Onehouraftertheinjectionofrolipramonday16,micewerekilledand
theirbrainspreparedforimmunohistochemistryortheirhippocampidissectedandpunchedforimmunoblotanalysis.Barsaremeans(cid:5)SEM;n(cid:6)8–10(a,b)or4(c–e);*p(cid:9)0.05,**p(cid:9)0.01
versuscorrespondingNCplusvehicle(Veh).H,Hilus.
PDE4B)inthebrainofPDE4D-deficientmiceshouldpotentiate
the memory-enhancing effect. However, this was not the case;
rolipramdidnotaltermemoryinPDE4D-deficientmice,indi-
catingapredominantroleofPDE4Dinmediatingmemory.The
importanceofPDE4Dformemoryappearstobeconsistentwith
thefindingsthatmicedeficientinPDE4Bdonotexhibitchanges
inmemory(Siuciaketal.,2008;Zhangetal.,2008)andissup-
portedbyseveralotherstudies.First,selectivePDE4Dallosteric
modulatorsnotonlyreversescopolamine-inducedmemoryim-
pairmentbutalsoenhancememoryontheirowninmice(Burgin
etal.,2010).Second,hippocampalLTPisenhancedinPDE4D-
deficientmice,althoughamygdala-dependent,fear-conditioning
memory is unexpectedly impaired (Rutten et al., 2008). Third,
Figure8. MicedeficientinPDE4D(4DKO)ortreatedwithrolipram(Rol)or4DmiRsdisplayed increasedexpressionofPDE4DinducedbyhighdosesofPDE4
differenteffectsonxylazine/ketamine-inducedanesthesia.Lentiviral4DmiR(4(cid:1)106TU/(cid:2)l/ inhibitorsimpairsmemory(Giorgietal.,2004).Nevertheless,a
side)wasinfusedintobilateraldentategyri2weeksbeforethetest;xylazine(10mg/kg)and potential role of PDE4A in memory cannot be excluded given
ketamine(80mg/kg)wereinjected(i.p.)15minafterrolipram(1mg/kg)orvehicle.Once
that this subtype is also highly expressed in the hippocampus
animalsbecameataxic,theywereplacedontheirbacksuntiltheyrightedthemselvesthree
(CherryandDavis,1999;Perez-Torresetal.,2000;McPheeetal.,
timeswithin30s.Thedurationofanesthesiawasdeterminedasthetimebetweenthelossand
returnoftherightingreflex.Barsaremeans(cid:5)SEM;n(cid:6)10–16;*p(cid:9)0.05,**p(cid:9)0.01versus 2001).
vehicle(Veh). TheroleofPDE4Dinmemoryappearstobeattributedtoits
regulationofcAMP/CREBsignaling.Consistentwiththeobser-
vations in WT mice treated with rolipram, mice deficient in
hasbeenlackofevidencefortheroleofPDE4Dinmemory.Here
PDE4DalsoconcurrentlydisplayedincreasedpCREBinthehip-
we demonstrated that mice deficient in PDE4D displayed en-
hanced hippocampal-dependent memory, in particular long- pocampus and enhanced memory in tests for hippocampal-
term memory, in different tests, suggesting that PDE4D is dependent memory; the former is consistent with increases in
importantinmemory.Thiswasconfirmedbyadministrationof cAMPconcentrationsinbraintissuesandprofounddecreasesin
rolipraminPDE4D-deficientmice,astrategythathasbeenused PDE4 activity in the hippocampus of PDE4D-deficient mice
toverifythecontributionofPDE4Dtoaspecificbehavioralpro- (Zhang et al., 2002). These findings and rolipram-unaltered
file(Zhangetal.,2002).IfPDE4Disnotimportant,inhibitionby pCREBin4DKOmicesuggestthatPDE4DisanimportantPDE4
rolipramoftheremainedPDE4subtypes(primarilyPDE4Aand subtyperesponsibleformemorymediatedbycAMP/CREBsig-

## Page 10

Lietal.•PDE4D,Neurogenesis,andMemory J.Neurosci.,January5,2011•31(1):172–183•181
naling,althoughfurtherstudiesusingPDE4A-deficientmiceare long-formPDE4Ds(i.e.,PDE4D7-9,11)werenotexaminedbe-
requiredtoestablishtheroleofPDE4A. causeofthelackofspecificantibodies,theresultssuggestthatat
PDE4-mediatedcAMP/CREBsignalingplaysacriticalrolein least the PDE4D4/5 variants are importantly involved in these
theregulationofadultneurogenesis(Nakagawaetal.,2002a,b; processes.Furtherstudiesusingsimilargenesilencingtechniques
Sasakietal.,2007;Lietal.,2009),whichisassociatedwithlearn- arerequiredtodeterminetheroleofotherlong-formPDE4Ds
ingandmemory(Shorsetal.,2001;vanPraagetal.,2002).Con- andvariantsofotherPDE4subtypes,inparticularPDE4A5and
sistentwiththis,chronictreatmentwithrolipramatadosethat PDE4A10, that are highly expressed in the hippocampus
increased pCREB and enhanced memory increased BrdU- (McPheeetal.,2001;D’Saetal.,2005)inmemory.
positivecellsinthedentategyrusofWTmice2weeksafterBrdU It was noted that chronic rolipram treatment differentially
injections,atwhichtimeBrdU-labeledcellssurvivedinsteadof alteredPDE4variants,i.e.,decreasedexpressionofPDE4D4,D5,
proliferated(SchmidtandDuman,2007).Theneurogeniceffect A5,andB1,increasedexpressionofPDE4D3,butdidnotalter
ofrolipramwasmimickedbyPDE4Ddeficiency,whichincreased PDE4B4inthehippocampus.Theseresultsareconsistentwith
BrdU-positive cells (primarily survival) in the dentate gyrus to previousfindings(Dlabogaetal.,2006).Regardless,theeffectsof
levelssimilartothoseseenfollowingchronicrolipramtreatment. rolipram on memory, pCREB, and neurogenesis did not differ
GiventhatrolipramdidnotaltertheneurogeniceffectofPDE4D from those of combined rolipram and PDE4D-miRNAs, sup-
deficiencyandthatmicedeficientinPDE4Bdisplayonlyaslight porting an important role for PDE4D4 and PDE4D5 in these
increase in cell proliferation but not in survival of neurons processes.Again,theroleofotherPDE4variantssuchasPDE4A5
(Zhangetal.,2008),PDE4DappearstobethemajorPDE4sub- andPDE4A10cannotbeexcludedgiventhattheyarehighlyex-
typeresponsibleforhippocampalneurogenesis. pressed in the hippocampus (McPhee et al. 2001; D’Sa et al.,
Rolipramhasbeenshowntoincreasehippocampalneurogen- 2005).Otherlong-formPDE4Dsmayalsocontributetotheef-
esisbyincreasingamplifyingneuralprogenitors(ANPs)(Lietal., fects of 4DmiR. Further studies are required to clarify these
2009), which divided into neuroblasts and eventually mature issues.
neuronsduringthepostmitoticphase(Encinasetal.,2006).At Interestingly,miRNA-induceddownregulationofPDE4Din
thedosethatincreasedhippocampalneurogenesisandpCREB, thehippocampusdidnotalter(cid:1)2adrenergicreceptor-mediated
rolipramincreasedexpressionofSox2,amarkerofneuralpro- anesthesia,asurrogatemeasureofemesisinnonvomitingspecies
genitorcells(Grahametal.,2003;Episkopou,2005),inthehip- (Robichaudetal.,2001,2002a).Incontrast,rolipramtreatment
pocampus but did not change the phenotype of BrdU-positive orPDE4Ddeficiencydecreasedthedurationofanesthesia;thisis
cells in the present and previous studies (Malberg et al., 2000; consistentwiththecontributionofPDE4and,morespecifically,
Nakagawaetal.,2002b;Lietal.,2009).Similarly,PDE4Ddefi- PDE4Dtoemesis,themajorsideeffectofPDE4inhibitors(Dyke
ciencyalsoincreasedhippocampalSox2,whichwasnotaltered andMontana,2002;Robichaudetal.,2001,2002a,b).
byrolipram;itdidnotchangetheproportionofnewbornneu- Insummary,usingbehavioral,neurochemical,immunohis-
rons among BrdU-positive cells. Therefore, PDE4D deficiency tochemical, and molecular biological approaches, we demon-
increases hippocampal neurogenesis most likely by acting on stratedforthefirsttimetherolesofPDE4Danditslong-form
ANPsinsteadofdirectlytargetingthepostmitoticphaseofpro- isoformsincAMP/CREBsignaling-mediatedmemoryandneu-
genitorcells. rogenesis. Manipulations targeting long-form PDE4Ds in the
The major challenge of gene knock-out techniques is gene hippocampusmayaltercAMP/CREBsignalinginamannerthat
deficiencythroughoutthewholebody,whichmayleadtoabnor- affectsmemoryandhippocampalneurogenesisbutavoidseme-
maldevelopment(Jinetal.,1999)andemesis(Robichaudetal., sis. These are supported by the findings that selective PDE4D
2002b).Toovercomethese,weusedmiRNAs,oneoftheRNAi allostericmodulatorsincompletelyinhibitPDE4activityanden-
techniquesforgenesilencing(ZeringueandConstantine-Paton, hancememorybuthavereducedpotentialtocauseemesis(Bur-
2004; Cullen, 2005), to knock down the long-form PDE4Ds, ginetal.,2010).Ourresultsmaybebeneficialfortreatmentof
giventhatlong-formPDE4Dsare:(1)highlyregulatedbyPKA memorylossassociatedwithneurodegenerativedisorderssuchas
andERKandcontainbindingsitesforprotein-proteininterac- Alzheimer’sdisease.
tions(Houslay,2010);(2)importantforintracellularcAMPhy-
drolysis(Baillieetal.,2000);and(3)relativelyhighlyexpressedin References
thehippocampus(Miroetal.,2002;Richteretal.,2005).Gene AbelT,KandelE (1998) Positiveandnegativeregulatorymechanismsthat
mediatelong-termmemorystorage.BrainResBrainResRev26:360–378.
silencing of PDE4 splice variants has been achieved in vitro by
BaillieGS,MacKenzieSJ,McPheeI,HouslayMD (2000) Sub-familyselec-
using siRNAs targeting a specific variant of PDE4B or PDE4D
tiveactionsintheabilityofErk2MAPkinasetophosphorylateandreg-
(Lynchetal.,2005;Lietal.,2006).Whileitisdifficulttotarget
ulatetheactivityofPDE4cyclicAMP-specificphosphodiesterases.BrJ
individualPDE4Disoformsbecauseoftheirhighhomologies,we Pharmacol131:811–819.
designedamiRNAsequencetotargetnucleotides642-662ofthe BaradM,BourtchouladzeR,WinderDG,GolanH,KandelE (1998) Rolip-
PDE4Dcodingsequence,whichcorrespondstoaminoacids214- ram,atypeIV-specificphosphodiesteraseinhibitor,facilitatestheestab-
221 within the UCR1 domain of long-form PDE4D isoforms lishmentoflong-lastinglong-termpotentiationandimprovesmemory.
ProcNatlAcadSciUSA95:15020–15025.
(Bolgeretal.,1997).WeusedlentivirusasthevectorformiRNAs
BarcoA,PittengerC,KandelER (2003) CREB,memoryenhancementand
given that lentiviral vector-mediated miRNAs produce stable,
thetreatmentofmemorydisorders:promises,pitfallsandprospects.Ex-
long-term, and neuron-specific gene suppression (Dull et al., pertOpinTherTargets7:101–114.
1998;Zuffereyetal.,1998;Stegmeieretal.,2005;Schrattetal., BolgerGB,McPheeI,HouslayMD (1996) AlternativesplicingofcAMP-
2006;Grilloetal.,2007),incontrasttosyntheticsiRNAs(Zentilin specificphosphodiesterasemRNAtranscripts:characterizationofanovel
andGiacca,2004).AsindicatedbyEGFP,lentiviralmiRNAswere tissue-specificisoform,RNPDE4A8.JBiolChem271:1065–1071.
Bolger GB, Erdogan S, Jones RE, Loughney K, Scotland G, Hoffmann R,
well expressed in the GCL of the dentate gyrus; long-form
WilkinsonI,FarrellC,HouslayMD (1997) Characterizationoffivedif-
PDE4D4andPDE4D5wereselectivelydownregulatedinthehip-
ferentproteinsproducedbyalternativelysplicedmRNAsfromthehuman
pocampus,leadingtoincreasesinhippocampalneurogenesisand cAMP-specificphosphodiesterasePDE4Dgene.BiochemJ328:539–548.
pCREB levels and enhancement of memory. While the other BourtchouladzeR,LidgeR,CatapanoR,StanleyJ,GossweilerS,Romashko

## Page 11

182•J.Neurosci.,January5,2011•31(1):172–183 Lietal.•PDE4D,Neurogenesis,andMemory
D,ScottR,TullyT (2003) AmousemodelofRubinstein-Taybisyn- mediateddownregulationofhypothalamicinsulinreceptorexpression.
drome:defectivelong-termmemoryisamelioratedbyinhibitorsofphos- PhysiolBehav92:691–701.
phodiesterase4.ProcNatlAcadSciUSA100:10518–10522. HansenG,JinS,UmetsuDT,ContiM (2000) Absenceofmuscariniccho-
BoyesBE,KimSU,LeeV,SungSC (1986) Immunohistochemicalcolocal- linergicairwayresponsesinmicedeficientinthecyclicnucleotidephos-
izationofS-100(cid:3)andtheglialfibrillaryacidicproteininratbrain.Neu- phodiesterasePDE4D.ProcNatlAcadSciUSA97:6751–6756.
roscience17:857–865. Houslay MD (2001) PDE4 cAMP-specific phosphodiesterases. Prog Nu-
Bruel-JungermanE,LarocheS,RamponC (2005) Newneuronsintheden- cleicAcidResMolBiol69:249–315.
tategyrusareinvolvedintheexpressionofenhancedlong-termmemory Houslay MD (2010) Underpinning compartmentalised cAMP signalling
followingenvironmentalenrichment.EurJNeurosci21:513–521. throughtargetedcAMPbreakdown.TrendsBiochemSci35:91–100.
BurginAB,MagnussonOT,SinghJ,WitteP,StakerBL,BjornssonJM,Thor- Houslay MD, Baillie GS, Maurice DH (2007) cAMP-Specific phospho-
steinsdottirM,HrafnsdottirS,HagenT,KiselyovAS,StewartLJ,Gurney diesterase-4enzymesinthecardiovascularsystem:amoleculartoolbox
ME (2010) Designofphosphodiesterase4D(PDE4D)allostericmodu- forgeneratingcompartmentalizedcAMPsignaling.CircRes100:950–
lators for enhancing cognition with improved safety. Nat Biotechnol 966.
28:63–70. HustonE,LumbS,RussellA,CatterallC,RossAH,SteeleMR,BolgerGB,
ChandrasekaranA,TohKY,LowSH,TaySK,BrennerS,GohDL (2008) PerryMJ,OwensRJ,HouslayMD (1997) Molecularcloningandtran-
IdentificationandcharacterizationofnovelmousePDE4Disoforms:mo- sientexpressioninCOS7cellsofanovelhumanPDE4BcAMP-specific
lecularcloning,subcellulardistributionanddetectionofisoform-specific phosphodiesterase,HSPDE4B3.BiochemJ328:549–558.
intracellularlocalizationsignals.CellSignal20:139–153. ImanishiT,SawaA,IchimaruY,MiyashiroM,KatoS,YamamotoT,UekiS
CherryJA,DavisRL (1999) CyclicAMPphosphodiesterasesarelocalizedin (1997) Amelioratingeffectsofrolipramonexperimentallyinducedim-
regionsofthemousebrainassociatedwithreinforcement,movement, pairments of learning and memory in rodents. Eur J Pharmacol
andaffect.JCompNeurol407:287–301. 321:273–278.
CheungYF,KanZ,Garrett-EngeleP,GallI,MurdochH,BaillieGS,Camargo JinSL,RichardFJ,KuoWP,D’ErcoleAJ,ContiM (1999) Impairedgrowth
LM, Johnson JM, Houslay MD, Castle JC (2007) PDE4B5, a novel, andfertilityofcAMP-specificphosphodiesterasePDE4D-deficientmice.
super-short, brain-specific cAMP phosphodiesterase-4 variant whose ProcNatlAcadSciUSA96:11998–12003.
isoform-specifying N-terminal region is identical to that of cAMP JohnstonLA,ErdoganS,CheungYF,SullivanM,BarberR,LynchMJ,Baillie
phosphodiesterase-4D6(PDE4D6).JPharmacolExpTher322:600–609. GS,VanHeekeG,AdamsDR,HustonE,HouslayMD (2004) Expres-
ContiM,RichterW,MehatsC,LiveraG,ParkJY,JinC (2003) CyclicAMP- sion,intracellulardistributionandbasisforlackofcatalyticactivityofthe
specificPDE4phosphodiesterasesascriticalcomponentsofcyclicAMP PDE4A7isoformencodedbythehumanPDE4AcAMP-specificphos-
signaling.JBiolChem278:5493–5496. phodiesterasegene.BiochemJ380:371–384.
CullenBR (2005) RNAithenaturalway.NatGenet37:1163–1165. KempermannG,GastD,KronenbergG,YamaguchiM,GageFH (2003)
deLimaMN,LaranjaDC,BrombergE,RoeslerR,Schro¨derN (2005) Pre- Earlydeterminationandlong-termpersistenceofadult-generatednew
orpost-trainingadministrationoftheNMDAreceptorblockerMK-801 neuronsinthehippocampusofmice.Development130:391–399.
impairsobjectrecognitionmemoryinrats.BehavBrainRes156:139–143. Kolosionek E, Savai R, Ghofrani HA, Weissmann N, Guenther A, Grim-
DlabogaD,HajjhusseinH,O’DonnellJM (2006) Regulationofphospho- mingerF,SeegerW,BanatGA,SchermulyRT,PullamsettiSS (2009)
diesterase-4(PDE4)expressioninmousebrainbyrepeatedantidepres- Expressionandactivityofphosphodiesteraseisoformsduringepithelial
santtreatment:comparisonwithrolipram.BrainRes1096:104–112. mesenchymaltransition:theroleofphosphodiesterase4.MolBiolCell
D’SaC,EischAJ,BolgerGB,DumanRS (2005) Differentialexpressionand 20:4751–4765.
regulationofthecAMP-selectivephosphodiesterasetype4Asplicevari- Li X, Huston E, Lynch MJ, Houslay MD, Baillie GS (2006) Phospho-
antsinratbrainbychronicantidepressantadministration.EurJNeurosci diesterase-4influencesthePKAphosphorylationstatusandmembrane
22:1463–1475. translocationofG-proteinreceptorkinase2(GRK2)inHEK-293beta2
DullT,ZuffereyR,KellyM,MandelRJ,NguyenM,TronoD,NaldiniL cellsandcardiacmyocytes.BiochemJ394:427–435.
(1998) Athird-generationlentivirusvectorwithaconditionalpackaging Li YF, Huang Y, Amsdell SL, Xiao L, O’Donnell JM, Zhang HT (2009)
system.JVirol72:8463–8471. Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4
DumanRS,MalbergJ,NakagawaS (2001) Regulationofadultneurogenesis (PDE4)inhibitorrolipramonbehaviordependoncyclicAMP-response
bypsychotropicdrugsandstress.JPharmacolExpTher299:401–407. element binding protein (CREB)-mediated neurogenesis in the hip-
DykeHJ,MontanaJG (2002) UpdateonthetherapeuticpotentialofPDE4 pocampus.Neuropsychopharmacology34:2404–2419.
inhibitors.ExpertOpinInvestigDrugs11:1–13. LynchMJ,BaillieGS,MohamedA,LiX,MaisonneuveC,KlussmannE,van
Egawa T, Mishima K, Matsumoto Y, Iwasaki K, Iwasaki K, Fujiwara M HeekeG,HouslayMD (2005) RNAsilencingidentifiesPDE4D5asthe
(1997) Rolipramanditsopticalisomers,phosphodiesterase4inhibitors, functionallyrelevantcAMPphosphodiesteraseinteractingwithbetaar-
attenuatedthescopolamine-inducedimpairmentsoflearningandmem- restintocontroltheproteinkinaseA/AKAP79-mediatedswitchingofthe
oryinrats.JpnJPharmacol75:275–281. beta2-adrenergicreceptortoactivationofERKinHEK293B2cells.JBiol
EncinasJM,VaahtokariA, EnikolopovG (2006) Fluoxetinetargetsearly Chem280:33178–33189.
progenitor cells in the adult brain. Proc Natl Acad Sci USA Lynex CN, Li Z, Chen ML, Toh KY, Low RW, Goh DL, Tay SK (2008)
103:8233–8238. Identification and molecular characterization of a novel PDE4D11
EpiskopouV (2005) SOX2functionsinadultneuralstemcells.TrendsNeu- cAMP-specificphosphodiesteraseisoform.CellSignal20:2247–2255.
rosci28:219–221. MacKenzieSJ,HouslayMD (2000) ActionofrolipramonspecificPDE4
EppJR,SpritzerMD,GaleaLA (2007) Hippocampus-dependentlearning cAMPphosphodiesteraseisoformsandonthephosphorylationofcAMP-
promotessurvivalofnewneuronsinthedentategyrusataspecifictime response-element-binding protein (CREB) and p38 mitogen-activated
duringcellmaturation.Neuroscience149:273–285. protein(MAP)kinaseinU937monocyticcells.BiochemJ347:571–578.
FujiokaT,FujiokaA,DumanRS (2004) ActivationofcAMPsignalingfacil- MalbergJE,EischAJ,NestlerEJ,DumanRS (2000) Chronicantidepressant
itatesthemorphologicalmaturationofnewbornneuronsinadulthip- treatment increases neurogenesis in adult hippocampus. J Neurosci
pocampus.JNeurosci24:319–328. 20:9104–9110.
GiorgiM,ModicaA,PompiliA,PacittiC,GasbarriA (2004) Theinduction MauriceT,Privat A (1997) SA4503,anovelcognitiveenhancerwith(cid:4)1
ofcyclicnucleotidephosphodiesterase4gene(PDE4D)impairsmemory receptoragonistproperties,facilitatesNMDAreceptor-dependentlearn-
inawatermazetask.BehavBrainRes154:99–106. inginmice.EurJPharmacol328:9–18.
GouldE,BeylinA,TanapatP,ReevesA,ShorsTJ (1999) Learningenhances McPheeI,CochranS,HouslayMD (2001) ThenovellongPDE4A10cyclic
adult neurogenesis in the hippocampal formation. Nat Neurosci AMPphosphodiesteraseshowsapatternofexpressionwithinbrainthatis
2:260–265. distinctfromthelongPDE4A5andshortPDE4A1isoforms.CellSignal
GrahamV,KhudyakovJ,EllisP,PevnyL (2003) SOX2functionstomain- 13:911–918.
tainneuralprogenitoridentity.Neuron39:749–765. MillarJK,PickardBS,MackieS,JamesR,ChristieS,BuchananSR,Malloy
GrilloCA,TamashiroKL,PiroliGG,MelhornS,GassJT,NewsomRJ,Rezni- MP,ChubbJE,HustonE,BaillieGS,ThomsonPA,HillEV,BrandonNJ,
kovLR,SmithA,WilsonSP,SakaiRR,ReaganLP (2007) Lentivirus- RainJC,CamargoLM,WhitingPJ,HouslayMD,BlackwoodDH,Muir

## Page 12

Lietal.•PDE4D,Neurogenesis,andMemory J.Neurosci.,January5,2011•31(1):172–183•183
WJ,PorteousDJ (2005) DISC1andPDE4Bareinteractinggeneticfac- roliprampromotessurvivalofnewbornhippocampalneuronsafterisch-
torsinschizophreniathatregulatecAMPsignaling.Science310:1187– emia.Stroke38:1597–1605.
1191. SchmidtHD,DumanRS (2007) Theroleofneurotrophicfactorsinadult
Miro´ X,Pe´rez-TorresS,Puigdome`nechP,PalaciosJM,MengodG (2002) hippocampalneurogenesis,antidepressanttreatmentsandanimalmod-
DifferentialdistributionofPDE4DsplicevariantmRNAsinratbrain elsofdepressive-likebehavior.BehavPharmacol18:391–418.
suggestsassociationwithspecificpathwaysandpresynapticallocalization. SchneiderHH (1984) BraincAMPresponsetophosphodiesteraseinhibi-
Synapse45:259–269. tors in rats killed by microwave irradiation or decapitation. Biochem
MontiB,BerteottiC,ContestabileA (2006) Subchronicrolipramdelivery Pharmacol33:1690–1693.
activates hippocampal CREB and Arc, enhances retention and slows SchrattGM,TuebingF,NighEA,KaneCG,SabatiniME,KieblerM,Green-
down extinction of conditioned fear. Neuropsychopharmacology bergME (2006) Abrain-specificmicroRNAregulatesdendriticspine
31:278–286. development.Nature439:283–289.
MorrisRG,GarrudP,RawlinsJN,O’KeefeJ (1982) Placenavigationim- ShorsTJ,MiesegaesG,BeylinA,ZhaoM,RydelT,GouldE (2001) Neuro-
pairedinratswithhippocampallesions.Nature297:681–683. genesisintheadultisinvolvedintheformationoftracememories.Nature
MullenR,BuckCR,SmithAM (1992) NeuN,aneuronalspecificnuclear 410:372–376.
proteininvertebrates.Development116:201–211. SiuciakJA,McCarthySA,ChapinDS,MartinAN (2008) Behavioraland
NakagawaS,KimJE,LeeR,MalbergJE,ChenJ,SteffenC,ZhangYJ,Nestler neurochemical characterization of mice deficient in the phospho-
EJ,DumanRS (2002a) Regulationofneurogenesisinadultmousehip- diesterase-4B(PDE4B)enzyme.Psychopharmacology197:115–126.
pocampusbycAMPandthecAMPresponseelement-bindingprotein. StegmeierF,HuG,RicklesRJ,HannonGJ,ElledgeSJ (2005) Alentiviral
JNeurosci22:3673–3682. microRNA-basedsystemforsingle-copypolymeraseII-regulatedRNA
NakagawaS,KimJE,LeeR,ChenJ,FujiokaT,MalbergJ,TsujiS,DumanRS
interference in mammalian cells. Proc Natl Acad Sci USA 102:
(2002b) LocalizationofphosphorylatedcAMPresponseelementbind-
13212–13217.
ing protein in immature neurons of adult hippocampus. J Neurosci
vanPraagH,SchinderAF,ChristieBR,ToniN,PalmerTD,GageFH (2002)
22:9868–9876.
Functionalneurogenesisintheadulthippocampus.Nature415:1030–
Ne´mozG,ZhangR,SetteC,ContiM (1996) IdentificationofcyclicAMP-
1034.
phosphodiesterasevariantsfromthePDE4Dgeneexpressedinhuman
VilligerJW,DunnAJ (1981) Phosphodiesteraseinhibitorsfacilitatemem-
peripheralmononuclearcells.FEBSLett384:97–102.
oryforpassiveavoidanceconditioning.BehavNeuralBiol31:354–359.
O’Donnell JM, Zhang HT (2004) Antidepressant effects of inhibitors of
Zala D, Bensadoun JC, Pereira de Almeida L, Leavitt BR, Gutekunst CA,
cAMPphosphodiesterase(PDE4).TrendsPharmacolSci25:158–163.
Aebischer P, Hayden MR, De´glon N (2004) Long-term lentiviral-
OtmakhovN,KhibnikL,OtmakhovaN,CarpenterS,RiahiS,AsricanB,
mediated expression of ciliary neurotrophic factor in the striatum of
LismanJ (2004) Forskolin-inducedLTPintheCA1hippocampalregion
Huntington’sdiseasetransgenicmice.ExpNeurol185:26–35.
isNMDAreceptordependent.JNeurophysiol91:1955–1962.
ZentilinL,GiaccaM (2004) Invivotransferandexpressionofgenescoding
PaxinosG,FranklinKBJ (2001) Themousebraininstereotaxiccoordinates.
forshortinterferingRNAs.CurrPharmBiotechnol5:341–347.
Ed2.SanDiego:Academic.
Zeringue HC, Constantine-Paton M (2004) Post-transcriptional gene si-
Pe´rez-TorresS,Miro´X,PalaciosJM,Corte´sR,Puigdome´nechP,MengodG
lencinginneurons.CurrOpinNeurobiol14:654–659.
(2000) Phosphodiesterasetype4isozymesexpressioninhumanbrain
ZhangHT (2009) CyclicAMP-specificphosphodiesterase-4asatargetfor
examined by in situ hybridization histochemistry and [3H]rolipram
thedevelopmentofantidepressantdrugs.CurrPharmDes15:1688–1698.
binding autoradiography: comparison with monkey and rat brain.
Zhang HT, O’Donnell JM (2000) Effects of rolipram on scopolamine-
JChemNeuroanat20:349–374.
inducedimpairmentofworkingandreferencememoryintheradial-arm
RemondesM,SchumanEM (2004) Roleforacorticalinputtohippocampal
mazetestsinrats.Psychopharmacology150:311–316.
area CA1 in the consolidation of a long-term memory. Nature 431:
ZhangHT,CrissmanAM,DorairajNR,ChandlerLJ,O’DonnellJM (2000)
699–703.
Inhibition of cyclic AMP phosphodiesterase (PDE4) reverses memory
RichterW,JinSL,ContiM (2005) Splicevariantsofthecyclicnucleotide
deficitsassociatedwithNMDAreceptorantagonism.Neuropsychophar-
phosphodiesterasePDE4Daredifferentiallyexpressedandregulatedin
rattissue.BiochemJ388:803–811. macology23:198–204.
RobichaudA,SavoieC,StamatiouPB,TattersallFD,ChanCC (2001) PDE4 ZhangHT,HuangY,JinSL,FrithSA,SuvarnaN,ContiM,O’DonnellJM
inhibitorsinduceemesisinferretsviaanoradrenergicpathway.Neuro- (2002) Antidepressant-likeProfileandReducedSensitivitytoRolipram
pharmacology40:262–269. inMiceDeficientinthePDE4DPhosphodiesteraseEnzyme.Neuropsy-
RobichaudA,SavoieC,StamatiouPB,LachanceN,JolicoeurP,RasoriR, chopharmacology27:587–595.
ChanCC (2002a) AssessingtheemeticpotentialofPDE4inhibitorsin Zhang HT, Zhao Y, Huang Y, Dorairaj NR, Chandler LJ, O’Donnell JM
rats.BrJPharmacol135:113–118. (2004) Inhibitionofthephosphodiesterase4(PDE4)enzymereverses
RobichaudA,StamatiouPB,JinSL,LachanceN,MacDonaldD,Laliberte´F, memorydeficitsproducedbyinfusionoftheMEKinhibitorU0126into
LiuS,HuangZ,ContiM,ChanCC (2002b) Deletionofphosphodies- theCA1subregionoftherathippocampus.Neuropsychopharmacology
terase4Dinmiceshortensalpha(2)-adrenoceptor-mediatedanesthesia,a 29:1432–1439.
behavioralcorrelateofemesis.JClinInvest110:1045–1052. ZhangHT,HuangY,SuvarnaNU,DengC,CrissmanAM,HopperAT,De
Romano A, Delorenzi A, Pedreira ME, Tomsic D, Maldonado H (1996) VivoM,RoseGM,O’DonnellJM (2005) EffectsofthenovelPDE4in-
AcuteadministrationofapermeantanalogofcAMPandaphosphodies- hibitorsMEM1018andMEM1091onmemoryintheradial-armmaze
terase inhibitor improve long-term habituation in the crab Chasmag- andinhibitoryavoidancetestsinrats.Psychopharmacology179:613–619.
nathus.BehavBrainRes75:119–125. ZhangHT,HuangY,MasoodA,StolinskiLR,LiY,ZhangL,DlabogaD,Jin
RuttenK,MisnerDL,WorksM,BloklandA,NovakTJ,SantarelliL,Wallace SL,ContiM,O’DonnellJM (2008) Anxiogenic-likebehavioralpheno-
TL (2008) Enhancedlong-termpotentiationandimpairedlearning typeofmicedeficientinphosphodiesterase4B(PDE4B).Neuropsycho-
in phosphodiesterase 4D-knockout (PDE4D) mice. Eur J Neurosci pharmacology33:1611–1623.
28:625–632. ZuffereyR,DullT,MandelRJ,BukovskyA,QuirozD,NaldiniL,TronoD
SasakiT,KitagawaK,Omura-MatsuokaE,TodoK,TerasakiY,SugiuraS, (1998) Self-inactivatinglentivirus vectorforsafeandefficient invivo
HatazawaJ,YagitaY,HoriM (2007) Thephosphodiesteraseinhibitor genedelivery.JVirol72:9873–9880.

